A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gedatolisib|DRUG: Palbociclib|DRUG: Letrozole|DRUG: Fulvestrant
Sponsor: Celcuity Inc